Randomized Trial to Compare Renal Function and Ductal Response between Indomethacin and Ibuprofen Treatment in Extremely Low Birth Weight Infants

Neonatology

Volumn 111, Issue 3, 2017, Pages 195-202

  Lin, Yuh Jyh ^a   Chen, Chung Ming ^b,c,d   Rehan, Virender K ^g   Florens, Adrian ^h   Wu, Shou Yien ^h   Tsai, Min Luen ^e   Kuo, Yung T ^c,f   Huang, Fu Kuei ^e   Yeh, Tsu F ^b,e,f,g  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c Institute of Clinical Pharmacy and Pharmaceutical Sciences   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h John H Stroger Hospital of Cook County   (United States)

Author keywords

Extremely low birth weight infants; Ibuprofen; Indomethacin; Patent ductus arteriosus

Indexed keywords

CREATININE; FUROSEMIDE; IBUPROFEN; INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR PARAMETERS; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; FLUID INTAKE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; INFANT; KIDNEY FUNCTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PROSTAGLANDIN URINE LEVEL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA; STUDY; URINE VOLUME; BLOOD; CLINICAL TRIAL; DRUG EFFECTS; DUCTUS ARTERIOSUS; ECHOCARDIOGRAPHY; KIDNEY; MULTICENTER STUDY; NEWBORN; PHYSIOLOGY; TAIWAN; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES;

CREATININE; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; DUCTUS ARTERIOSUS; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; KIDNEY; MALE; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84995769245     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000450822     Document Type: Article

References (27)

1. Clyman RI: Ibuprofen and patent ductus arteriosus. N Engl J Med 2000; 343: 728-730.
2. Jones LJ, Craven PD, Attia J, Thakkinstian A, Wright I: Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal Ed 2011; 96:F45-F52.
3. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD: Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000; 47: 36-42.
4. Thomas RL, Parker GC, van Overmeire B, Aranda JV: A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005; 164: 135-140.
5. van Overmeire B, Smets K, Lecoutere D, van de Broek H, Weyler J, Degroote K, Langhendries JP: A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343: 674-681.
6. Yeh TF, Raval D, Luken J, Thalji A, Lilien L, Pildes RS: Clinical evaluation of premature infants with patent ductus arteriosus: a scoring system with echocardiogram, acid-base, and blood gas correlations. Crit Care Med 1981; 9: 655-657.
7. Yeh TF, Achanti B, Patel H, Pildes RS: Indomethacin therapy in premature infants with patent ductus arteriosus-determination of therapeutic plasma levels. Dev Pharmacol Ther 1989; 12: 169-178.
8. Fleiss JL, Levin B, Paik MC (eds): Statistical Methods for Rates and Proportions, ed 3. New York, John Wiley and Sons, 2003, pp 64-85.
9. Ohlsson A, Walia R, Shah SS: Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev 2015;CD003481.
10. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS: Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983; 102: 895-906.
11. van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwe W, Jespers A, Weyler J, Harrewijn I, Langhendries JP: Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1945-1949.
12. Yeh TF, Luken JA, Thalji A, Raval D, Carr I, Pildes RS: Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus-A double-blind controlled study. J Pediatr 1981; 98: 137-145.
13. Yeh TF, Luken J, Raval D, Thalji A, Carr I, Pildes RS: Indomethacin treatment in small versus large premature infants with ductus arteriosus: comparison of plasma indomethacin concentration and clinical response. Br Heart J 1983; 50: 27-30.
14. Clyman RI: Mechanisms regulating the ductus arteriosus. Biol Neonate 2006; 89: 330-335.
15. Drukker A, Guignard JP: Ibuprofen-lysine for closure of patent ductus arteriosus. Acta Paediatr 2001; 90: 465-466.
16. Hirt D, van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, Schepens P, Urien S: An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol 2008; 65: 629-636.
17. Guignard JP, Drukker A: Why do newborn infants have a high plasma creatinine? Pediatrics 1999; 103:e49.
18. Reyes JL, Melendez E: Effects of eicosanoids on the water and sodium balance of the neonate. Pediatr Nephrol 1990; 4: 630-634.
19. DeWitt DL, Meade EA, Smith WL: PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. Am J Med 1993; 95: 40S-44S.
20. Gleason CA: Prostaglandins and the developing kidney. Semin Perinatol 1987; 11: 12-21.
21. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D: Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992; 267: 25934-25938.
22. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR: Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 1999; 96: 7563-7568.
23. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR: Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90: 11693-11697.
24. Bancalari E, Claure N, Gonzalez A: Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 2005; 88: 192-201.
25. Watterberg KL, Scott SM, Backstrom C, Gifford KL, Cook KL: Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics 2000; 105: 320-324.
26. Betkerur MV, Yeh TF, Miller K, Glasser RJ, Pildes RS: Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics 1981; 68: 99-102.
27. Antonucci R, Cuzzolin L, Arceri A, Fanos V: Urinary prostaglandin E2 in the newborn and infant. Prostaglandins Other Lipid Mediat 2007; 84: 1-13.